: Regeneron CFO Landry to retire, top accountant Fenimore to become CFO


Regeneron Pharmaceuticals Inc. REGN, +0.66% said late Friday that Chief Financial Officer Robert E. Landry will retire in February, and Christopher Fenimore, the pharma company’s current head of accounting and controller, will succeed Landry upon his retirement. Fenimore joined the company in 2003, Regeneron said. Shares of Regeneron rose 0.5% in the extended session Friday after ending the regular trading day up 0.7%.

This article was originally published by Marketwatch.com. Read the original article here.

Previous articleThe Ratings Game: Taylor Swift is propping up the hotel industry, analysts say, amid questions about revenge-travel fluctuations
Next articleStocks close slightly higher but can’t salvage losing week


Please enter your comment!
Please enter your name here